Dallah Healthcare Company announced that its board of directors has approved the resignation of the board member, Dr. Fahad bin Abdulaziz Al-Rabiah, from the membership of the board of directors and compensation and remuneration committee, effective from November 15, 2022 due to his personal reasons.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
165.8 SAR | -1.54% | -1.31% | -3.49% |
May. 13 | Dallah Healthcare Posts Higher Q1 Net Profit, Revenue | MT |
Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.49% | 4.39B | |
-18.84% | 16.76B | |
+3.60% | 12.65B | |
+3.98% | 11.86B | |
+4.28% | 10.28B | |
+28.60% | 8.67B | |
-6.94% | 7.6B | |
+6.40% | 6.8B | |
+8.59% | 6.52B | |
+39.21% | 4.53B |
- Stock Market
- Equities
- 4004 Stock
- News Dallah Healthcare Company
- Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee